Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 5, 2002, Pages 576-578

  Nieto, Jose J ^a   Gornall, Robert ^a   Toms, Ellen ^a   Clarkson, Suzanne ^a   Hogston, Patrick ^a   Woolas, Robert P ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADENOCARCINOMA; ARTICLE; CANCER STAGING; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORBIDITY; PALPATION; PERITONEAL BIOPSY; PRIORITY JOURNAL; BIOPSY; ENDOMETRIUM TUMOR; METHODOLOGY; OMENTUM; PATHOLOGY; PERITONEUM TUMOR; PREOPERATIVE CARE; PROSPECTIVE STUDY;

ADENOCARCINOMA; BIOPSY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OMENTUM; PERITONEAL NEOPLASMS; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 0036562105     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2002.01272.x     Document Type: Article

References (6)

1. Woolas R.P., Oram D.H. Current management of endometrial carcinoma. Studd J. 1994;181-194 RCOG Press, London.
2. Orr J.W. Jr., Holloway R.W., Orr P.F., Holimon J.L. Surgical staging of uterine cancer: an analysis of perioperative morbidity. Gynecol Oncol. 42:1991;209-216.
3. Quinn M.A. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer. 6:1996;102-107.
4. Kadar N., Homesley H.D., Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol. 46:1992;145-149.
5. Sutton G.P. Peritoneal cytology in endometrial carcinoma. Cancer Treat Res. 49:1989;41-52.
6. Chen S.S., Spiegel G. Stage I endometrial carcinoma. Role of omental biopsy and omentectomy. J Reprod Med. 36:1991;627-629.